Extends Illinois rare disease commission five years

File SB4185 ("Extends Illinois rare disease commission five years") is before the Illinois Legislature and has not been decided. Latest step (April 10, 2026): Referred to Assignments.

Illinois file SB4185, before the Illinois Legislature. Still to be decided as of 2026-04-10.

What it does

Rare disease patients keep state advocacy support five more years Illinoisans with rare diseases retain access to the Rare Disease Commission's research coordination, clinical trial matching, and patient advocacy services through January 1, 2032 instead of losing them in 2027.

The bigger picture

Department of Public Health continues disease tracking and reporting The Illinois Department of Public Health maintains its infrastructure for printing and distributing the Commission's annual reports on rare disease prevalence, research gaps, and patient outcomes to clinicians and policymakers.

What to watch

Commission still expires in 2032 unless renewed again The five-year extension is temporary; without further legislative action, the Commission will sunset in 2032, potentially disrupting continuity of rare disease research coordination and patient support at that time.

Official summary

Amends the Rare Disease Commission Act. Changes the sunset date of the Act from January 1, 2027 to January 1, 2032. In provisions regarding administrative support, adds that the administrative and other support to the Rare Disease Commission provided by the Department of Public Health includes printing services related to the distribution of the Commission's annual report. Effective immediately.

Read the official record for SB4185

See everything up for a vote · This week in Illinois · See what we have filed with the clerk